Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
J Int Soc Sports Nutr ; 18(1): 43, 2021 Jun 07.
Article in English | MEDLINE | ID: mdl-34098980

ABSTRACT

BACKGROUND: The aim of this study was to investigate if the supplementation with Opuntia ficus-indica (OFI) juice may affect plasma redox balance and heart rate variability (HRV) parameters following a maximal effort test, in young physically active women. METHODS: A randomized, double blind, placebo controlled and crossover study comprising eight women (23.25 ± 2.95 years, 54.13 ± 9.05 kg, 157.75 ± 0.66 cm and BMI of 21.69 ± 0.66 kg/m2) was carried out. A juice containing OFI diluted in water and a Placebo solution were supplied (170 ml; OFI = 50 ml of OFI juice + 120 ml of water; Placebo = 170 ml beverage without Vitamin C and indicaxanthin). Participants consumed the OFI juice or Placebo beverage every day for 3 days, before performing a maximal cycle ergometer test, and for 2 consecutive days after the test. Plasma hydroperoxides and total antioxidant capacity (PAT), Skin Carotenoid Score (SCS) and HRV variables (LF, HF, LF/HF and rMSSD) were recorded at different time points. RESULTS: The OFI group showed significantly lower levels of hydroperoxides compared to the Placebo group in pre-test, post-test and 48-h post-test. PAT values of the OFI group significantly increased compared to those of the Placebo group in pre-test and 48-h post-test. SCS did not differ between groups. LF was significantly lower in the OFI group 24-h after the end of the test, whereas rMSSD was significantly higher in the OFI group 48-h post-test. CONCLUSION: OFI supplementation decreased the oxidative stress induced by intense exercise and improved autonomic balance in physically active women.


Subject(s)
Exercise/physiology , Fruit and Vegetable Juices , Heart Rate , Opuntia , Oxidative Stress , Adult , Autonomic Nervous System/physiology , Cross-Over Studies , Double-Blind Method , Female , Humans , Hydrogen Peroxide/blood , Oxidation-Reduction , Oxygen Consumption , Young Adult
2.
Molecules ; 25(21)2020 Oct 30.
Article in English | MEDLINE | ID: mdl-33143282

ABSTRACT

Manna is produced from the spontaneous solidification of the sap of some Fraxinus species, and, owing its content in mannitol, is used in medicine as a mild laxative. Manna is also a rich source of characteristic bio-phenols with reducing, antioxidant and anti-inflammatory properties. This study assesses the activity of a hydrophilic extract of manna (HME) on cellular and molecular events in human colon-rectal cancer cells. HME showed a time- and concentration-dependent anti-proliferative activity, measured by MTT assay, in all the cell lines examined, namely Caco-2, HCT-116 and HT-29. The amounts of HME that caused 50% of cell death after a 24 h treatment were 8.51 ± 0.77, 10.73 ± 1.22 and 28.92 ± 1.99 mg manna equivalents/mL, respectively; no toxicity was observed in normally differentiated Caco-2 intestinal cells. Hydroxytyrosol, a component of HME known for its cytotoxic effects on colon cancer cells, was ineffective, at least at the concentration occurring in the extract. Through flow-cytometric techniques and Western blot analysis, we show that HME treatment causes apoptosis, assessed by phosphatidylserine exposure, as well as a loss of mitochondrial membrane potential, an intracellular formation of reactive oxygen species (ROS), increases in the levels of cleaved PARP-1, caspase 3 and Bax, and a decrease in Bcl-2 expression. Moreover, HME interferes with cell cycle progression, with a block at the G1/S transition. In conclusion, the phytocomplex extracted from manna exerts an anti-proliferative activity on human colon cancer cells through the activation of mitochondrial pathway-mediated apoptosis and cell cycle arrest. Our data may suggest that manna could have the potential to exert chemo-preventive effects for the intestine.


Subject(s)
Antineoplastic Agents, Phytogenic , Apoptosis/drug effects , Cell Cycle Checkpoints/drug effects , Colonic Neoplasms/drug therapy , Fraxinus/chemistry , Mitochondria/metabolism , Plant Extracts , Antineoplastic Agents, Phytogenic/chemistry , Antineoplastic Agents, Phytogenic/pharmacology , Caco-2 Cells , Colonic Neoplasms/metabolism , Colonic Neoplasms/pathology , Gene Expression Regulation, Neoplastic/drug effects , HT29 Cells , Humans , Mitochondria/pathology , Neoplasm Proteins/biosynthesis , Plant Extracts/chemistry , Plant Extracts/pharmacology
3.
Biomolecules ; 10(7)2020 07 02.
Article in English | MEDLINE | ID: mdl-32630700

ABSTRACT

Combining phytochemicals with chemotherapics is an emerging strategy to treat cancer to overcome drug toxicity and resistance with natural compounds. We assessed the effects of indicaxanthin (Ind), a pigment obtained from Opuntia ficus-indica (L. Mill) fruit, combined with cisplatin (CDDP) against cervical cancer cells (HeLa). Measured cell viability via Trypan blue assay; cell morphology via fluorescence microscopy; apoptosis, cell cycle, mitochondrial membrane potential (MMP) and cell redox balance via flow-cytometry; expression levels of apoptosis-related proteins via western blot. Cell viability assays and Chou-Talalay plot demonstrated that the combination of CDDP and Ind had synergistic cytotoxic effects. Combined treatment had significant effects (p < 0.05) on phosphatidylserine externalization, cell morphological changes, cell cycle arrest, fall in MMP, ROS production and GSH decay compared with the individual treatment groups. Bax, cytochrome c, p53 and p21waf1 were over-expressed, while Bcl-2 was downregulated. Pre-treatment with N-acetyl-l-cysteine abolished the observed synergistic effects. We also demonstrated potentiation of CDDP anticancer activity by nutritionally relevant concentrations of Ind. Oxidative stress-dependent mitochondrial cell death is the basis of the chemosensitizing effect of Ind combined with CDDP against HeLa cancer cells. ROS act as upstream signaling molecules to initiate apoptosis via p53/p21waf1 axis. Ind can be a phytochemical of interest in combo-therapy.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/pharmacology , Betaxanthins/pharmacology , Cisplatin/pharmacology , Cyclin-Dependent Kinase Inhibitor p21/metabolism , Pyridines/pharmacology , Tumor Suppressor Protein p53/metabolism , Cell Proliferation/drug effects , Cell Survival/drug effects , Drug Synergism , Gene Expression Regulation, Neoplastic/drug effects , HeLa Cells , Humans , Membrane Potential, Mitochondrial/drug effects , Oxidative Stress/drug effects , Proto-Oncogene Proteins c-bcl-2/metabolism , Reactive Oxygen Species/metabolism
4.
Biomolecules ; 10(5)2020 05 16.
Article in English | MEDLINE | ID: mdl-32429353

ABSTRACT

BACKGROUND: Eryptosis is a physiological, apoptosis-like death of injured erythrocytes crucial to prevent premature haemolysis and the pathological sequalae generated by cell-free haemoglobin. When dysregulated, the process is associated to several inflammatory-based pathologies. 4-Hydroxy-trans-2-nonenal (HNE) is an endogenous signalling molecule at physiological levels and, at higher concentrations, is involved in the pathogenesis of several inflammatory-based diseases. This work evaluated whether HNE could induce eryptosis in human erythrocytes. METHODS: Measurements of phosphatidylserine, cell volume, intracellular oxidants, Ca++, glutathione, ICAM-1, and ceramide were assessed by flow cytometry. Scanning electron microscopy evaluated morphological alterations of erythrocytes. Western blotting assessed caspases. PGE2 was measured by ELISA. Adhesion of erythrocytes on endothelial cells was evaluated by gravity adherence assay. RESULTS: HNE in the concentration range between 10-100 µM induces eryptosis, morphological alterations correlated to caspase-3 activation, and increased Ca++ levels. The process is not mediated by redox-dependent mechanisms; rather, it strongly depends on PGE2 and ceramide. Interestingly, HNE induces significant increase of erythrocytes adhesion to endothelial cells (ECs) that are in turn dysfunctionated as evident by overexpression of ICAM-1. CONCLUSIONS: Our results unveil a new physiopathological role for HNE, provide mechanistic details of the HNE-induced eryptosis, and suggest a novel mechanism through which HNE could exert pro-inflammatory effects.


Subject(s)
Aldehydes/pharmacology , Eryptosis , Erythrocytes/drug effects , Lipid Peroxidation , Adult , Calcium/metabolism , Cell Adhesion , Cells, Cultured , Erythrocytes/metabolism , Erythrocytes/physiology , Erythrocytes/ultrastructure , Glutathione/metabolism , Human Umbilical Vein Endothelial Cells/physiology , Humans , Intercellular Adhesion Molecule-1/metabolism , Middle Aged , Phosphatidylserines/metabolism
5.
Antioxidants (Basel) ; 8(10)2019 Oct 18.
Article in English | MEDLINE | ID: mdl-31635261

ABSTRACT

Manna, a very singular vegetable product derived from the spontaneous solidification of the sap of some Fraxinus species, has long been known for its mild laxative and emollient properties. In this work, a hydro-alcoholic extract of manna (HME) from Sicilian Fraxinus angustifolia Vahl was investigated using HPLC-DAD to find phenol components and using chemical and biological in vitro assays to determine its reducing, antioxidant and anti-inflammatory capacity. We identified elenolic acid, tyrosol, hydroxytyrosol, catechin, fraxetin, verbascoside, gallic acid, procyanidin-B1, and luteolin 3,7 glucoside, in order of abundance. Measurements of total antioxidant activity by Folin-Ciocalteu reaction and ferric reducing ability (FRAP), as well as of scavenger activity towards ABTS•+, DPPH•, and perferryl-myoglobin radicals, showed that the phytocomplex effectively reduced oxidants with different standard potentials. When compared with vitamin E, HME also behaved as an efficient chain-breaking antioxidant against lipoperoxyl radicals from methyl linoleate. In cellular models for oxidative stress, HME counteracted membrane lipid oxidation of human erythrocytes stimulated by tert-butyl hydroperoxide and prevented the generation of reactive oxygen species, as well as the GSH decay in IL-1ß-activated intestinal normal-like cells. Moreover, in this in vitro intestinal bowel disease model, HME reduced the release of the pro-inflammatory cytokines IL-6 and IL-8. These findings may suggest that manna acts as an antioxidant and anti-inflammatory natural product in humans, beyond its well-known effects against constipation.

6.
Eur J Med Chem ; 179: 753-764, 2019 Oct 01.
Article in English | MEDLINE | ID: mdl-31284085

ABSTRACT

Over the latest years phytochemical consumption has been associated to a decreased risk of both the onset and the development of a number of pathological conditions. In this context indicaxanthin, a betalain pigment from Opuntia ficus-indica fruit, has been the object of sound research. Explored, at first, for its mere antioxidant potential, Indicaxanthin is now regarded as a redox-active compound able to exert significant poly-pharmacological effects against several targets in a number of experimental conditions both in vivo and in vitro. This paper aims to provide an overview on the therapeutical effects of indicaxanthin, ranging from the anti-inflammatory to the neuro-modulatory and anti-tumoral ones and favored by its high bioavailability. Moreover, biochemical and molecular modelling investigations are aimed to identify the pharmacological targets the compound is able to interact with and to address the challenging development in the future research.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Betaxanthins/pharmacology , Biological Products/pharmacology , Fruit/chemistry , Neoplasms/drug therapy , Neuroprotective Agents/pharmacology , Phytochemicals/pharmacology , Pyridines/pharmacology , Animals , Antineoplastic Agents, Phytogenic/chemistry , Antineoplastic Agents, Phytogenic/isolation & purification , Betaxanthins/chemistry , Betaxanthins/isolation & purification , Biological Products/chemistry , Biological Products/isolation & purification , Blood-Brain Barrier/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , Humans , Inflammation/drug therapy , Mice , Mice, Inbred C57BL , Models, Molecular , Molecular Structure , Neoplasms/pathology , Neuroprotective Agents/chemistry , Neuroprotective Agents/isolation & purification , Opuntia/chemistry , Phytochemicals/chemistry , Phytochemicals/isolation & purification , Pyridines/chemistry , Pyridines/isolation & purification , Structure-Activity Relationship
7.
Toxicology ; 411: 43-48, 2019 01 01.
Article in English | MEDLINE | ID: mdl-30385265

ABSTRACT

Cigarette smoking has been linked with oxidative stress and inflammation. In turn, eryptosis, the suicidal erythrocyte death similar to apoptosis that can be triggered by oxidative stress, has been associated with chronic inflammatory diseases including atherosclerosis. However, the link between smoking and eryptosis has not been explored so far. The aim of the present study was to determine the level of eryptotic erythrocytes in healthy male smokers (n = 21) compared to non-smokers (n = 21) and assess its relationship with systemic inflammation (CRP) as well as with antioxidant defense (GSH) and their resistance to ex-vivo induced hemolysis. Smoking caused an increase in phosphatidylserine translocation outside the erythrocyte membrane (hallmark of eryptosis), significantly correlated to the plasma level of CRP (r = 0.546) and GSH concentration in erythrocytes (r=-0.475). With respect to non-smokers, smokers show a marginal increase of total leucocytes and erythrocyte volume, no modifications of the RBC resistance to oxidative stress-induced hemolysis and hematological and lipid parameters unvaried. We conclude that the inflammatory status (high CRP levels) and RBC oxidative stress (low GSH levels) caused by cigarette smoking are associated with an increase of eryptotic erythrocytes, a yet unknown relationship potentially involved with atherosclerosis and cardiovascular disease in smokers.


Subject(s)
Antioxidants/metabolism , C-Reactive Protein/metabolism , Eryptosis , Smokers , Smoking/adverse effects , Adult , Cross-Sectional Studies , Erythrocyte Membrane/drug effects , Erythrocyte Membrane/metabolism , Glutathione/blood , Health Status , Hemolysis/drug effects , Humans , In Vitro Techniques , Leukocyte Count , Male , Middle Aged , Oxidative Stress/drug effects , Phosphatidylserines/blood , Young Adult
8.
J Agric Food Chem ; 63(33): 7353-60, 2015 Aug 26.
Article in English | MEDLINE | ID: mdl-26227670

ABSTRACT

Indicaxanthin is a bioactive and bioavailable betalain pigment from the Opuntia ficus-indica fruits. In this in vivo study, kinetic measurements showed that indicaxanthin is revealed in the rat brain within 1 h from oral administration of 2 µmol/kg, an amount compatible with a dietary consumption of cactus pear fruits in humans. A peak (20 ± 2.4 ng of indicaxanthin per whole brain) was measured after 2.5 h; thereafter the molecule disappeared with first order kinetics within 4 h. The potential of indicaxanthin to affect neural activities was in vivo investigated by a microiontophoretic approach. Indicaxanthin, administered in a range between 0.085 ng and 0.34 ng per neuron, dose-dependently modulated the rate of discharge of spontaneously active neurons of the hippocampus, with reduction of the discharge and related changes of latency and duration of the effect. Indicaxanthin (0.34 ng/neuron) showed inhibitory effects on glutamate-induced excitation, indicating activity at the level of glutamatergic synapses. A molecular target of indicaxanthin is suggested by in silico molecular modeling of indicaxanthin with N-methyl-D-aspartate receptor (NMDAR), the most represented of the glutamate receptor family in hippocampus. Therefore, at nutritionally compatible amounts indicaxanthin (i) crosses the rat BBB and accumulates in brain; (ii) can affect the bioelectric activity of hippocampal neurons locally treated with amounts comparable with those measured in the brain; and (iii) modulates glutamate-induced neuronal excitation. The potential of dietary indicaxanthin as a natural neuromodulatory agent deserves further mechanistic and neurophysiologic investigation.


Subject(s)
Betaxanthins/pharmacology , Blood-Brain Barrier/drug effects , Hippocampus/drug effects , Hippocampus/physiology , Opuntia/chemistry , Pyridines/pharmacology , Animals , Betaxanthins/administration & dosage , Betaxanthins/pharmacokinetics , Electrophysiology/methods , Male , Neurons/drug effects , Neurons/physiology , Pyridines/administration & dosage , Pyridines/pharmacokinetics , Rats, Wistar , Receptors, Glutamate/metabolism
9.
J Drug Target ; 23(10): 910-25, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26000952

ABSTRACT

2-Amino-N-[2-(3,4-dihydroxy-phenyl)-ethyl]-3-phenyl-propionamide (DA-PHEN) has been previously synthesized to obtain a potential prodrug capable of release dopamine (DA) into CNS. However, DA-PHEN could act per se as a dopaminergic drug. In this study, the permeability transport (Pe), obtained by parallel artificial permeability assay (PAMPA), indicated a low passive transcellular transport (Pe = 0.32 ± 0.01 × 10(-6 )cm/s). Using the Caco-2 cell system, the Papp AP-BL in absorptive direction (3.36 ± 0.02 × 10(-5 )cm/s) was significantly higher than the Papp BL-AP in secretive direction (1.75 ± 0.07 × 10(-5 )cm/s), suggesting a polarized transport. The efflux ratio (Papp AP-BL/Papp BL-AP = 0.52 ± 0.02) indicated a low affinity of DA-PHEN to efflux carriers. The forced swim test highlighted a reduction of immobility time in both pre-test and test sessions (p < 0.0001), with an exacerbation in the number of headshakes and divings in the pretest (p < 0.0001). Morris water maze strengthened the hypothesis that DA-PHEN induces adaptive responses to environmental challenges which are involved on cognitive functions (DA-PHEN versus CTR: escape latency; p < 0.001; distance swum p < 0.001, time spent on target quadrant p < 0.001), without any change in locomotor activity for the administered dose. The molecular docking revealed the interaction of DA-PHEN with the identified D1 site mapping human brain receptor.


Subject(s)
Blood-Brain Barrier/drug effects , Dopamine Agents/pharmacokinetics , Dopamine/analogs & derivatives , Phenylalanine/analogs & derivatives , Caco-2 Cells , Dopamine/pharmacokinetics , Humans , Molecular Docking Simulation , Permeability , Phenylalanine/pharmacokinetics , Transcytosis
10.
Mar Drugs ; 13(4): 1901-24, 2015 Apr 03.
Article in English | MEDLINE | ID: mdl-25854642

ABSTRACT

A new series of nortopsentin analogues, in which the imidazole ring of the natural product was replaced by thiazole and the indole unit bound to position 2 of the thiazole ring was substituted by a 7-azaindole moiety, was efficiently synthesized. Two of the new nortopsentin analogues showed good antiproliferative effect against the totality of the NCI full panel of human tumor cell lines (~60) having GI50 values ranging from low micromolar to nanomolar level. The mechanism of the antiproliferative effect of these derivatives, investigated on human hepatoma HepG2 cells, was pro-apoptotic, being associated with externalization of plasma membrane phosphatidylserine and mitochondrial dysfunction. Moreover, the compounds induced a concentration-dependent accumulation of cells in the subG0/G1phase, while confined viable cells in G2/M phase.


Subject(s)
Antineoplastic Agents/chemical synthesis , Drug Design , Imidazoles/chemical synthesis , Indoles/chemical synthesis , Neoplasms/drug therapy , Pyridines/chemical synthesis , Pyrroles/chemical synthesis , Alkaloids/chemical synthesis , Alkaloids/chemistry , Alkaloids/pharmacology , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , G2 Phase/drug effects , Halogenation , Humans , Imidazoles/chemistry , Imidazoles/pharmacology , Indoles/chemistry , Indoles/pharmacology , Membrane Potential, Mitochondrial/drug effects , Methylation , Mitochondria/drug effects , Mitochondria/pathology , Molecular Structure , Neoplasms/pathology , Pyridines/chemistry , Pyridines/pharmacology , Pyrroles/chemistry , Pyrroles/pharmacology , Resting Phase, Cell Cycle/drug effects , Thiazoles/chemical synthesis , Thiazoles/chemistry , Thiazoles/pharmacology
11.
Mar Drugs ; 13(1): 460-92, 2015 Jan 16.
Article in English | MEDLINE | ID: mdl-25603343

ABSTRACT

Two new series of nortopsentin analogues, in which the imidazole ring of the natural product was replaced by thiazole and indole units were both substituted by 7-azaindole moieties or one indole unit was replaced by a 6-azaindole portion, were efficiently synthesized. Compounds belonging to both series inhibited the growth of HCT-116 colorectal cancer cells at low micromolar concentrations, whereas they did not affect the viability of normal-like intestinal cells. A compound of the former series induced apoptosis, evident as externalization of plasma membrane phosphatidylserine (PS), and changes of mitochondrial trans-membrane potential, while blocking the cell cycle in G2/M phase. In contrast, a derivative of the latter series elicited distinct responses in accordance with the dose. Thus, low concentrations (GI30) induced morphological changes characteristic of autophagic death with massive formation of cytoplasmic acid vacuoles without apparent loss of nuclear material, and with arrest of cell cycle at the G1 phase, whereas higher concentrations (GI70) induced apoptosis with arrest of cell cycle at the G1 phase.


Subject(s)
Cell Proliferation/drug effects , Pyridines/chemical synthesis , Pyrroles/chemical synthesis , Thiazoles/chemical synthesis , Apoptosis/drug effects , Dose-Response Relationship, Drug , G2 Phase/drug effects , HCT116 Cells/drug effects , Humans , Membrane Potential, Mitochondrial/drug effects , Molecular Structure , Pyridines/pharmacology , Pyrroles/pharmacology , Thiazoles/pharmacology
12.
J Nutr ; 144(2): 185-92, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24306215

ABSTRACT

Nutritional research has shifted recently from alleviating nutrient deficiencies to chronic disease prevention. We investigated the activity of indicaxanthin, a bioavailable phytochemical of the betalain class from the edible fruit of Opuntia ficus-indica (L. Miller) in a rat model of acute inflammation. Rat pleurisy was achieved by injection of 0.2 mL of λ-carrageenin in the pleural cavity, and rats were killed 4, 24, and 48 h later; exudates were collected to analyze inflammatory parameters, such as nitric oxide (NO), prostaglandin E(2) (PGE(2)), interleukin-1ß (IL-1ß), and tumor necrosis factor-α (TNF-α); cells recruited in pleura were analyzed for cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS) expression, and nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) activation. Indicaxanthin (0.5, 1, or 2 µmol/kg), given orally before carrageenin, time- and dose-dependently, reduced the exudate volume (up to 70%) and the number of leukocytes recruited in the pleural cavity (up to 95%) at 24 h. Pretreatment with indicaxanthin at 2 µmol/kg inhibited the carrageenin-induced release of PGE(2) (91.4%), NO (67.7%), IL-1ß (53.6%), and TNF-α (71.1%), and caused a decrease of IL-1ß (34.5%), TNF-α (81.6%), iNOS (75.2%), and COX2 (87.7%) mRNA, as well as iNOS (71.9%) and COX-2 (65.9%) protein expression, in the recruited leukocytes. Indicaxanthin inhibited time- and dose- dependently the activation of NF-κB, a key transcription factor in the whole inflammatory cascade. A pharmacokinetic study with a single 2 µmol/kg oral administration showed a maximum 0.22 ± 0.02 µmol/L (n = 15) plasma concentration of indicaxanthin, with a half-life of 1.15 ± 0.11 h. When considering the high bioavailability of indicaxanthin in humans, our findings suggest that this dietary pigment has the potential to improve health and prevent inflammation-based disorders.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Betaxanthins/therapeutic use , Inflammation Mediators/metabolism , Inflammation/diet therapy , Opuntia/chemistry , Phytotherapy , Pleurisy/diet therapy , Pyridines/therapeutic use , Animals , Anti-Inflammatory Agents/pharmacology , Betaxanthins/pharmacology , Carrageenan , Disease Models, Animal , Fruit/chemistry , Inflammation/chemically induced , Inflammation/drug therapy , Inflammation/metabolism , Leukocytes/metabolism , Male , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Pleural Cavity/drug effects , Pleural Cavity/metabolism , Pleurisy/chemically induced , Pleurisy/drug therapy , Pleurisy/metabolism , Pyridines/pharmacology , RNA, Messenger/metabolism , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...